BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1460 related articles for article (PubMed ID: 29568201)

  • 1. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
    Zhou HY; Wu CQ; Bi EX
    World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
    Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
    Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
    Liang B; Li Y; Wang T
    Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
    Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
    PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer.
    Wang XW; Wu Y; Wang D; Qin ZF
    Genet Mol Res; 2014 Oct; 13(4):8695-703. PubMed ID: 25366760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
    Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
    Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.
    Martins MR; Almeida RS; Lucena-Silva N; Coutinho-Camilo CM; Torjal I; Dos Santos RL; Miranda-Furtado CL; Rios ÁFL; Torres LC; Begnami MDFS
    Med Oncol; 2019 Aug; 36(9):81. PubMed ID: 31399867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.
    Wei C; Gao JJ
    PeerJ; 2019; 7():e7882. PubMed ID: 31637133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.